Compounds > erythromycin
Page last updated: 2024-08-21

erythromycin and bucladesine

erythromycin has been researched along with bucladesine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Abe, M; Hara, N; Hidaka, K; Mitsuyama, T; Tanaka, T1
Abe, M; Furuno, T; Hara, N; Hidaka, K; Mitsuyama, T; Tanaka, T1
Henquin, JC; Nenquin, M1

Other Studies

4 other study(ies) available for erythromycin and bucladesine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Inhibition by erythromycin of superoxide anion production by human polymorphonuclear leukocytes through the action of cyclic AMP-dependent protein kinase.
    Respiration; international review of thoracic diseases, 1995, Volume: 62, Issue:5

    Topics: Adrenergic beta-Agonists; Bucladesine; Chronic Disease; Cyclic AMP-Dependent Protein Kinases; Erythromycin; Humans; Isoproterenol; L-Lactate Dehydrogenase; Neutrophils; Protein Synthesis Inhibitors; Respiratory Tract Diseases; Superoxides

1995
Inhibition by erythromycin of human pulmonary artery endothelial cell injury induced by human neutrophils.
    Respiration; international review of thoracic diseases, 1997, Volume: 64, Issue:3

    Topics: Anti-Bacterial Agents; Bucladesine; Cells, Cultured; Endothelium, Vascular; Erythromycin; Fura-2; Humans; L-Lactate Dehydrogenase; Neutrophils; Pulmonary Artery; Superoxide Dismutase

1997
Sulphonylurea receptor-1, sulphonylureas and amplification of insulin secretion by Epac activation in β cells.
    Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:7

    Topics: Acetylcysteine; Animals; Bucladesine; Cyclic AMP-Dependent Protein Kinases; Erythromycin; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice, Inbred C57BL; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide

2016